Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Communications Medicine|May 23, 2022
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adultsAngelika Wagner, Angela Guzek, Johanna Ruff, et al.
Journal of Biological Rhythms|November 11, 2022
The Association of Time of Day of ChAdOx1 nCoV-19 Vaccine Administration With SARS-CoV-2 Anti-Spike IgG Antibody Levels: An Exploratory Observational StudyAstrid C Erber, Angelika Wagner, Marianna Karachaliou, et al.
Scientific Reports|April 24, 2025
Red flags for depression and PTSD following acute myocardial infarction: the role of early psychological symptomsOmid Amouzadeh-Ghadikolai, Dirk von Lewinski, Jolana Wagner-Skacel, et al.
Vaccines|May 25, 2024
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron VariantsAngelika Wagner, Erika Garner-Spitzer, Claudia Auer, et al.
Frontiers in Medicine|March 4, 2022
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 YearErika Garner-Spitzer, Angelika Wagner, Michael Kundi, et al.
Wiener Klinische Wochenschrift|July 3, 2026
[Vaccination of immunocompromised individuals: Expert opinion - update 2026]Ursula Wiedermann, Angelika Wagner, Alexander Bartuschka, et al.
Ebiomedicine|September 6, 2023
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formationErika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, et al.
Frontiers in Immunology|May 31, 2022
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel DiseaseAngelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort StudyDaniela Sieghart, Claudia A Hana, Helmuth Haslacher, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Pageof 3